1.
Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.
2.
3.
4.
5.
6.
7.
8.
9.
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib
Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial